We are live on
!
Find out more
PE
Point72 Europe Portfolio holdings
AUM
$2.04B
1-Year Est. Return
25.99%
This Fund
S&P 500
This Quarter
Est. Return
+0.84%
1 Year Est. Return
+25.99%
3 Year Est. Return
+95.43%
5 Year Est. Return
+195.42%
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
+$93.4M
(+8.3%)
Cap. Flow
+$85.7M
Cap. Flow
% of AUM
7.05%
Top 10 Holdings %
Top 10 Hldgs %
28.55%
Holding
171
New
71
Increased
31
Reduced
26
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$32.1M |
| 2 |
ConocoPhillips
COP
|
+$29M |
| 3 |
Coca-Cola Europacific Partners
CCEP
|
+$26M |
| 4 |
Blue Owl Capital
OWL
|
+$22M |
| 5 |
International Flavors & Fragrances
IFF
|
+$19.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$38.9M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$23.4M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$23M |
| 4 |
Aramark
ARMK
|
+$20.9M |
| 5 |
Chevron
CVX
|
+$17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.97% |
| 2 | Healthcare | 22.51% |
| 3 | Energy | 14.83% |
| 4 | Technology | 10.88% |
| 5 | Materials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Vistra
VST
$50.1B
| $3.04M | 0.25% |
+35,400
| New | +$2.96M |
|
|
JKS
102
JinkoSolar
JKS
$782M
| $3.02M | 0.25% |
+145,900
| New | +$3.59M |
|
103
Netflix
NFLX
$301B
| $3M | 0.25% |
+44,500
| New | +$2.78M |
|
104
Fortis
FTS
$29.7B
| $2.99M | 0.25% |
+77,000
| New | +$3.04M |
|
105
Rivian
RIVN
$24.2B
| $2.94M | 0.24% |
+219,400
| New | +$2.29M |
|
106
Fluence Energy
FLNC
$1.68B
| $2.91M | 0.24% |
+168,000
| New | +$3.22M |
|
107
TG Therapeutics
TGTX
$8.4B
| $2.86M | 0.24% |
+160,769
| New | +$2.57M |
|
108
Axsome Therapeutics
AXSM
$12.1B
| $2.47M | 0.2% |
+30,741
| New | +$2.28M |
|
|
ITCI
109
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.21M | 0.18% |
+32,300
| New | +$2.24M |
|
110
Verizon
VZ
$201B
| $2.05M | 0.17% |
+49,800
| New | +$2.01M |
|
111
Lazard
LAZ
$4.21B
| $1.78M | 0.15% |
+46,600
| New | +$1.82M |
|
112
BioCryst Pharmaceuticals
BCRX
$2.48B
| $1.65M | 0.14% |
+267,649
| New | +$1.48M |
|
113
Saia
SAIA
$10.9B
| $1.61M | 0.13% |
+3,400
| New | +$1.58M |
|
114
General Motors
GM
$81.7B
| $1.56M | 0.13% |
+33,500
| New | +$1.51M |
|
115
Teck Resources
TECK
$28.8B
| $1.51M | 0.12% |
+31,600
| New | +$1.55M |
|
|
ALTM
116
DELISTED
Arcadium Lithium plc
ALTM
| $1.51M | 0.12% |
+450,200
| New | +$1.88M |
|
117
Duke Energy
DUK
$101B
| $1.5M | 0.12% |
+15,000
| New | +$1.5M |
|
|
BPMC
118
DELISTED
Blueprint Medicines
BPMC
| $1.46M | 0.12% |
+13,569
| New | +$1.36M |
|
119
Sanofi
SNY
$109B
| $1.31M | 0.11% |
+26,961
| New | +$1.3M |
|
120
Annexon
ANNX
$814M
| $1.15M | 0.09% |
+234,592
| New | +$1.21M |
|
|
121
Chevron
CVX
$374B
| $988K | 0.08% |
6,315
-106,548
| -94% | -$17M |
|
122
Legend Biotech
LEGN
$3.68B
| $985K | 0.08% |
+22,245
| New | +$1.03M |
|
123
Regeneron Pharmaceuticals
REGN
$72.9B
| $983K | 0.08% |
+935
| New | +$906K |
|
124
AstraZeneca
AZN
$267B
| $857K | 0.07% |
+5,498
| New | +$827K |
|
125
Acadia Pharmaceuticals
ACAD
$4.45B
| $822K | 0.07% |
+50,600
| New | +$817K |
|
Similar funds
PH
AF
CCA
PHK
TAM
FSC
CCB
LNWWM
Point72 Europe's Q2 2024 Portfolio in Review
As of Q2 2024, Point72 Europe held 171 positions worth $1.21B, up 8.3% from $1.12B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Point72 Europe deployed $85.7M of net new capital in Q2 2024, opening 71 new positions and adding to 31 existing holdings. Its largest new stake was ConocoPhillips: 238,684 shares worth $27.3M.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Chevron, an estimated $17M trimmed.
- Point72 Europe's largest Q2 2024 buy was ConocoPhillips: 238,684 shares worth $27.3M.
- Point72 Europe added most to CRH in Q2 2024, an estimated $32.1M increase.
- Point72 Europe's biggest Q2 2024 reduction was Chevron, cutting an estimated $17M.
- Point72 Europe fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2024, selling an estimated $38.9M.
- Point72 Europe's ten largest holdings make up 29% of its $1.21B portfolio in Q2 2024.
- Point72 Europe opened 71 new positions and closed 42 in Q2 2024.
- Point72 Europe's portfolio value rose 8.3% quarter-over-quarter to $1.21B.
Based on Point72 Europe's 13F filing for Q2 2024, filed 14 Aug 2024.